Promising new weight loss and diabetes treatment helps burn fat while keeping muscle in preclinical study
Over the past five years, medications called GLP-1s have revolutionized the treatment of metabolic disorders like obesity, diabetes and fatty liver disease. Sold under the brand names Ozempic, Wegovy, Mounjaro and Zepbound, these drugs are highly effective at helping people lose weight and manage their blood sugar levels. However, they do come with some risks.
In a groundbreaking preclinical study published in Science Advances, researchers from UC Berkeley have discovered a promising new treatment for obesity and diabetes that can help burn fat while preserving muscle mass. This novel approach, which increases energy expenditure rather than restricting calorie intake, has shown impressive results in mice.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
